Insider · CIK 0001560152
John A. Fallon
Files at COLL (COLLEGIUM PHARMACEUTICAL, INC). First filing Nov 14, 2025, latest Nov 14, 2025.
In brief
John A. Fallon files SEC Form 4 as director at COLL (COLLEGIUM PHARMACEUTICAL, INC). Since Nov 14, 2025, John A. Fallon has reported 0 open-market buys worth $0 and 1 open-market sell worth $1.6M, the latest filed on Nov 14, 2025.
A track record needs three past buys with six months of prices behind them; John A. Fallon has 0, so none is measured yet.
The newest scored trade: sold $1.6M of COLL on Nov 12, 2025, filed Nov 14, 2025, scored 43 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $1.6M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
COLL: COLLEGIUM PHARMACEUTICAL, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | COLLEGIUM PHARMACEUTICAL, INC | $1.6M 34,853 shares | -35% | +92% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 17, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | 13,920 0.04% of outstanding | $497k | Jul 17, 2026 | $294k |
| Jul 15, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | 8,095 0.03% of outstanding | $294k | Jul 15, 2026 | none |
| Nov 12, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 34,853 0.11% of outstanding | $1.6M | Nov 12, 2025 | none |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | MOption exercise Common Stock | +15,000 | $16.49 | $247k | 79,634 | Nov 14, 2025 |
| Nov 12, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | MOption exercise Common Stock | +19,853 | $9.33 | $185k | 99,487 | Nov 14, 2025 |
| Nov 12, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock | -34,853 | $47.21 | $1.6M | 64,634 | Nov 14, 2025 |
| Nov 12, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | MOption exercise Stock Option (Right to Purchase)derivative | -15,000 | $0.00 | $0 | 0 | Nov 14, 2025 |
| Nov 12, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | MOption exercise Stock Option (Right to Purchase)derivative | -19,853 | $0.00 | $0 | 0 | Nov 14, 2025 |
| May 15, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +9,791 | $0.00 | $0 | 64,634 | May 19, 2025 |
Questions about John A. Fallon
Answered from the filings on this page, as of the latest one.
Is John A. Fallon buying or selling?
In the last 12 months John A. Fallon reported 0 open-market buys worth $0 and 1 open-market sell worth $1.6M on SEC Form 4; the latest was sold $1.6M of COLL on Nov 12, 2025. Grants, option exercises and tax withholding are not counted.
How did John A. Fallon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John A. Fallon has 0.
Where does John A. Fallon file Form 4?
John A. Fallon has filed Form 4 at COLL (COLLEGIUM PHARMACEUTICAL, INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.